Menu
Fechar
hrs4r
Quiero donar
Firma
NÚRIA SALA-GONZÁLEZ
Posición
Investigador/a Pre-doctoral – R1
Investigadores/as Pre-doctorales – R1
Publicacions

Publicacions

Mehra N, Antonarakis ES, Park SH, Goh JC, McDermott R, Sala Gonzalez N, Fong PC, Greil R, De Santis M, Yanez PE, Huang YH, Begbie SD, Rey F, Kramer G, Suzuki H, Saretsky TL, Ghate SR, Cui Y, Hosius C, Yu EY

Patient-reported Outcomes in KEYLYNK-010: Pembrolizumab Plus Olaparib Versus Abiraterone or Enzalutamide for Participants with Biomarker-unselected, Previously Treated Metastatic Castration-resistant Prostate Cancer.

European Urology Oncology, 2025, 8, 1030-1040 dx.doi.org/10.1016/j.euo.2025.04.018
Jimeneza, N, de Herreros, MG, Reig, O, Marin-Aguilera, M, Aversa, C, Ferrer-Mileo, L, Garcia-Esteve, S, Rodriguez-Carunchio, L, Trias, I, Font, A, Rodriguez-Vida, A, Climent, MA, Crosi, S, Chirivellaj, I, Domenech, M, Figols, M, Carles, J, Suárez, C, Rivera, DH, González-Billalabeitia, E, Civico, C, Sála-Gonzálezp, N, de Porras, VR, Ribalr, MJ, Prat, A, Mellado, B

Development and independent validation of a prognostic gene expression signature based on RB1, PTEN, and TP53 in metastatic hormone-sensitive prostate cancer patients (vol 7, pg954-964 ,2024)

European Urology Oncology, 2025, 8 dx.doi.org/10.1016/j.euo.2025.05.011
Zapatero, A, Alonso-Gordoa, T, Antolín, AR, Couñago, F, Sanmamed, N, Esteban, MD, Valcárcel, ML, Manneh, R, Borque-Fernando, A, González, NS, Maroto, P

Triplet systemic therapy for hormone-sensitive prostate cancer: a critical review with a multidisciplinary approach

Oncology Reviews, 2025, 19 dx.doi.org/10.3389/or.2025.1599292
de Herreros, MG, Jiménez, N, Padrosa, J, Aversa, C, Ferrer-Mileo, L, García-Esteve, S, Rodríguez-Carunchio, L, Trias, I, Fernández-Mañas, L, Marín-Aguilera, M, Altamirano, M, Mazariegos, M, Font, A, Rodriguez-Vida, A, Climent, MA, Cros, S, Chirivella, I, Figols, M, Sala-González, N, de Porras, VR, Pardo, JC, Prat, A, Reig, O, Mellado, B

Clinical and Transcriptomic Characterization of Metastatic Hormone-Sensitive Prostate Cancer Patients with Low PTEN Expression

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 dx.doi.org/10.3390/ijms26136244
Sabaté-Ortega, J, Albert-Carrasco, M, Escribano-Ferrer, C, Grau-Manrubia, G, Fina-Planas, C, López-Núnez, C, Teixidor-Vilà, E, Bujons-Buscarons, E, Montañés-Ferrer, C, Sala-González, N

Case report: Uncommon gastric metastasis as a presentation of recurrent clear cell renal cell carcinoma

Frontiers in oncology, 2024, 14, 1354127-1354127 dx.doi.org/10.3389/fonc.2024.1354127
Borque-Fernando Á, Zapatero A, Manneh R, Alonso-Gordoa T, Couñago F, Domínguez-Esteban M, López-Valcárcel M, Rodríguez-Antolín A, Sala-González N, Sanmamed N, Maroto P

Recommendations on the treatment of metastatic hormone-sensitive prostate cancer: Patient selection.

Actas Urologicas Espanolas, 2024, 48, 623-631 dx.doi.org/10.1016/j.acuroe.2024.05.008
Jiménez, N, de Herreros, MG, Reig, O, Marin-Aguilera, M, Aversa, C, Ferrer-Mileo, L, Garcia-Esteve, S, Rodríguez-Carunchio, L, Trias, I, Font, A, Rodríguez-Vida, A, Climent, MA, Cros, S, Chirivella, I, Domènech, M, Figols, M, Carles, J, Suarez, C, Rivera, DH, González-Billalabeitia, E, Cívico, C, Sala-González, N, de Porras, VR, Ribal, MJ, Prat, A, Mellado, B

Development and Independent Validation of a Prognostic Gene Expression Signature Based on RB1, PTEN, and TP53 in Metastatic Hormone-sensitive Prostate Cancer Patients

European Urology Oncology, 2024, 7, 954-964 dx.doi.org/10.1016/j.euo.2023.12.012
Antonarakis ES, Park SH, Goh JC, Shin SJ, Lee JL, Mehra N, McDermott R, Sala-Gonzalez N, Fong PC, Greil R, Retz M, Sade JP, Yanez P, Huang YH, Begbie SD, Gafanov RA, De Santis M, Rosenbaum E, Kolinsky MP, Rey F, Chiu KY, Roubaud G, Kramer G, Sumitomo M, Massari F, Suzuki H, Qiu P, Zhang J, Kim J, Poehlein CH, Yu EY

Pembrolizumab Plus Olaparib for Patients With Previously Treated and Biomarker-Unselected Metastatic Castration-Resistant Prostate Cancer: The Randomized, Open-Label, Phase III KEYLYNK-010 Trial

JOURNAL OF CLINICAL ONCOLOGY, 2023, 41, 3839-3850 dx.doi.org/10.1200/JCO.23.00233
Sabaté Ortega J, Fort Culillas R, Escoda Garcia M, Vásquez-Dongo CA, Sala González N

Case Report: A Presentation of Early-Onset Immune-Mediated Bullous Pemphigoid in a Patient with Urothelial Cancer

CURRENT ONCOLOGY, 2023, 30, 7802-7809 dx.doi.org/10.3390/curroncol30090566
Sabaté-Ortega, J, Bujons-Buscarons, E, Fina-Planas, C, Vilanova-Anducas, N, Vidal-Sarró, N, Sala-González, N

Paraneoplastic dermatomyositis associated with urothelial cancer: report of a case and systematic review of the literature

Frontiers in oncology, 2023, 13 dx.doi.org/10.3389/fonc.2023.1223627

Formulari de contacte

Conoce el IDIBGI!

 menu